Looking Back at DIA 2026: June Edition
As DIA June 2026 concludes, we reflect on the conversations and connections that reinforced our shared commitment to advancing patient safety and shaping the future of pharmacovigilance.
Graph AI raises $3 million seed funding for drug safety platform
AI life sciences startup Graph AI has secured $3 million in seed funding to revolutionise pharmacovigilance. The California-based startup leverages AI-driven automation to address the inefficiencies and errors in traditional drug safety monitoring. This funding will accelerate product innovation and global market expansion for their SaaS platform.
Graph AI Raises $3 Mn To Automate Drug Safety Monitoring for Pharma Firms
Pharmaceutical-sector focussed AI startup Graph AI has secured $3 Mn (around INR 26.37 Cr) in its seed funding round led by Bessemer Venture Partners.
Graph AI: A service firm turned AI-native solution for pharma and life sciences
Four enterprise technologists stumbled onto one of pharma’s most manual workflows—and then rebuilt the process leaner and purpose-built for the AI era.